Pfizer Ends Sangamo Alliance With Gene Therapy for Hemophilia on Cusp of FDA Filing
Posted:
Pfizer is walking away from partner Sangamo Therapeutics ahead of expected regulatory submissions for the hemophilia A gene therapy they co-developed. Cash-strapped Sangamo said it is now looking for a new partner for the program.
Read the full article in the latest MedCity News blog post here.
St. Louis-based Ascension this week announced its new Clinical Innovation Institute, designed as a center of excellence devoted to vetting emerging technologies and harnessing that innovation for enterprise-wide growth, quality improvement, and improved patient and provider experience.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us